About N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide
N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide (PubChem CID 171534806) has the molecular formula C21H22F3N5O3
and a molecular weight of 449.43 g/mol. Its IUPAC name is N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide.
Molecular Properties
| Compound Name | N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide |
| PubChem CID | 171534806 |
| Molecular Formula | C21H22F3N5O3 |
| Molecular Weight | 449.43 g/mol |
| Exact Mass | 449.17 |
| IUPAC Name | N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide |
| SMILES | Cc1cnc(C(=O)N[C@H](c2nc3cc(C(F)(F)F)ccc3n2C)[C@]2(O)CCCOC2)cn1 |
| InChI | InChI=1S/C21H22F3N5O3/c1-12-9-26-15(10-25-12)19(30)28-17(20(31)6-3-7-32-11-20)18-27-14-8-13(21(22,23)24)4-5-16(14)29(18)2/h4-5,8-10,17,31H,3,6-7,11H2,1-2H3,(H,28,30)/t17-,20+/m1/s1 |
| InChIKey | BWMAYNAUOKBNFM-XLIONFOSSA-N |
| XLogP | 2.70 |
| TPSA | 102.16 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 449.43 |
| LogP ≤ 5 | 2.70 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide?
The IUPAC name of N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide (CID 171534806) is N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide.
What is the SMILES notation for N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide?
The canonical SMILES for N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide is Cc1cnc(C(=O)N[C@H](c2nc3cc(C(F)(F)F)ccc3n2C)[C@]2(O)CCCOC2)cn1.
What is the InChIKey of N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide?
The InChIKey is BWMAYNAUOKBNFM-XLIONFOSSA-N. The full InChI is InChI=1S/C21H22F3N5O3/c1-12-9-26-15(10-25-12)19(30)28-17(20(31)6-3-7-32-11-20)18-27-14-8-13(21(22,23)24)4-5-16(14)29(18)2/h4-5,8-10,17,31H,3,6-7,11H2,1-2H3,(H,28,30)/t17-,20+/m1/s1.
What are the key properties of N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide?
N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide has a molecular weight of 449.43 g/mol, XLogP of 2.70, 4 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(R)-[(3R)-3-hydroxyoxan-3-yl]-[1-methyl-5-(trifluoromethyl)benzimidazol-2-yl]methyl]-5-methylpyrazine-2-carboxamide is sourced from PubChem (CID 171534806), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).